| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Omeprazole Impurity G
|
125656-83-9 |
埃索美拉唑杂质H
|
9-甲氧基-1,3-二甲基-12-硫代-吡啶并[1',2':3,4]咪唑并[1,2-A]苯并咪唑-2(12H)-酮;奥美拉唑EP杂质G;埃索美拉唑杂质G(奥美拉唑EP杂质G);埃索美拉唑杂质G(奥美拉唑EP杂质G);奥美拉唑杂质1;奥美拉唑 G
|
C16H13N3O2S |
311.36 | |
|
Erythromycin A 6,9-Imino Ether
|
99290-97-8 |
红霉素A6,9 - 亚氨基醚
|
红霉素A6,9-亚氨基醚;阿奇霉素CP杂质Q;红霉素亚氨基醚;红霉素A6,9-亚氨基醚;红霉素A 6,9-亚胺醚;阿奇霉素杂质19;阿奇霉素杂质17;阿奇霉素CP杂质Q;阿奇霉素杂质7(红霉素A(6,9-氨基醚))
|
C37H66N2O12 |
730.92614 | 619-419-0 |
|
Azithromycin Impurity B
|
307974-61-4 |
阿奇霉素杂质B
|
阿奇霉素杂质B;阿奇霉素B;阿奇霉素杂质Ⅱ(杂质B)［阿奇霉素B］(2R,3R,4S,5R,8R,10R,11R,12S,13S,14R)-13-［［2,6-双脱氧-3-C-甲基-3-O-甲基-α-L-核糖-吡喃己糖基］氧］-2-乙基-4,10-二羟基-3,5,6,8,10,12,14-七甲基-11-［［3,4,6-三脱氧-3-(二甲氨基)-β-D-木糖-吡喃己糖基］氧］-1-氧杂-6-氮杂环十五烷-15-酮;阿奇霉素杂质Ⅱ(杂质B)[阿奇霉素B](2R,3R,4S,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-双脱氧-3-C-甲基-3-O-甲基-Α-L-核糖-吡喃己糖基]氧]-2-乙基-4,10-二羟基-3,5,6,8,10,12,14-七甲基-11-[[3,4,6-三脱氧-3-(二甲氨基)-Β-D-木糖-吡喃己糖基]氧]-1-氧杂-6-氮杂环十五烷-15-酮;阿奇霉素EP杂质B
|
C38H72N2O11 |
733 | |
|
Zonisamide Impurity 4
|
73101-65-2 |
唑尼沙胺氯
|
Zonisamide Impurity 4;BENZO[D]ISOXAZOL-3-YL-METHANESULFONYL CHLORIDE;1,2-BENZISOXAZOLE-3-METHANESULFONYL CHLORIDE;Benzo[d]isoxazol-3-yl-methanesulfonyl Chloride, technical grade;1,2-Benzisoxazole-3-methanesulfonic acid chloride;ZonisaMide Chloride;1,2-Benzoxazol-3-ylmethanesulfonyl chloride
|
C8H6ClNO3S |
231.66 | |
|
N-Methyl zonisamide
|
68292-02-4 |
N-甲基唑尼沙胺
|
N-甲基唑尼沙胺;N-甲基乙酰唑尼沙胺;唑尼沙胺N-甲基杂质(USP)
|
C9H10N2O3S |
226.2523 | |
|
Zolmitriptan EP Impurity A
|
139264-24-7 |
佐米曲坦R异构体
|
Zolmitriptan EP Impurity A;Zolmitriptan Impurity 3(R-Isomer);(4R)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone;(R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one;Zolmitriptan R-Isomer (20 mg) ((R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one);ZolMitriptan R-IsoMer;(R)-Zolmitriptan;(R)-4-[[3-[2-(DiMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-2-oxazolidinone
(ZolMitriptan R-IsoMer)
|
C16H21N3O2 |
287.35684 | |
|
(S)-N,N-Dimethyl-2-(5-((2-oxooxazolidin-4-yl)methyl)-1H-indol-3-yl)ethanamine oxide
|
251451-30-6 |
佐米曲坦N-氧化物
|
佐米曲坦N-氧化物;佐米曲普坦氧化物;佐米曲普坦N-氧化物
|
C16H21N3O3 |
303.36 | |
|
Zolmitriptan Related Compound D (20 mg) ((S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate)
|
191864-24-1 |
佐米曲坦USP RC D
|
佐米曲坦相关物质D;(S)-3-(2-二甲基氨基乙基)-5-(2-氧代-1,3-恶唑烷-4-基甲基)-1H-吲哚-2-羧酸乙酯;佐米曲坦USP RC D;佐米曲普坦杂质14
|
C19H25N3O4 |
359.4195 | |
|
Didesmethyl Zolmitriptan
|
139264-15-6 |
佐米曲坦双去甲基杂质
|
佐米曲坦双去甲基杂质;二去甲基佐米曲普坦;佐米曲普坦二甲基杂质
|
C14H16N3O2 |
258.29574 | |
|
ZiprasidoneEP Impurity E
|
1159977-04-4 |
齐拉西酮杂质E
|
齐拉西酮聚合杂质2;齐拉西酮杂质ê;ZIPRASIDONE EP杂质E;齐拉西酮杂质E;齐哌西酮杂质E;齐拉西酮EP杂质E
|
C28H24ClN5OS2 |
546.10606 | |
|
Ziprasidone EP Impurity C
|
1159977-64-6 |
齐拉西酮开环物,氨基酸杂质
|
齐拉西酮开环物,氨基酸杂质;2-氨基-5-[2-[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]乙基]-4-氯苯乙酸
|
C21H23ClN4O2S |
430.95092 | |
|
3-Oxo Ziprasidone(Ziprasidone Impurity B)
|
1159977-56-6 |
齐拉西酮杂质B
|
齐普拉西酮EP杂质B;齐拉西酮杂质B;齐哌西酮杂质B;齐拉西酮双酮杂质;5-[2-[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]乙基]-6-氯-1H-吲哚-2,3-二酮;齐拉西酮EP杂质B
|
C21H19ClN4O2S |
426.91916 | |
|
Vortioxetine Impurity 18
|
13616-83-6 |
DISULFIDE, BIS(2,4-DIMETHYLPHENYL)
|
沃替西汀杂质N:1,2-双(2,4-二甲基苯基)二硫醚;伏硫西汀杂质18;氢溴酸沃替西汀杂质N;沃替西汀杂质18;沃替西汀杂质N ;氢溴酸沃替西汀杂质N;沃替西汀杂质18
|
C16H18S2 |
274.44412 | 237-101-6 |
|
Vortioxetine Impurity 6
|
1293489-74-3 |
沃替西汀杂质C
|
1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine;Vortioxetine Impurity 6;Vortioxetine Imp.C;Vortioxetine impurity C;Vortioxetine impurity G: 1- [2- (3,4-dimethylphenylthio) phenyl] piperazine
|
|||
|
Vortioxetine Impurity 4
|
1293489-77-6 |
沃替西汀杂质4
|
伏硫西汀杂质4;沃替西汀杂质D:1-[2-(2,3-二甲基苯硫基)苯基]哌嗪;伏氧西汀杂质4;沃替西汀杂质4
|
C18H22N2S |
298.44568 | |
|
Vortioxetine Impurity 2
|
1293489-69-6 |
沃替西汀杂质2
|
伏硫西汀杂质2;沃替西汀杂质B:1-[2-(3-甲基苯硫基)苯基]哌嗪;伏氧西汀杂质2
|
C17H20N2S |
284.4191 | |
|
Vortioxetine Impurity 1
|
1293489-71-0 |
沃替西汀杂质A
|
沃替西汀杂质A:1-[2-(2-甲基苯硫基)苯基]哌嗪;伏硫西汀杂质 1;沃替西汀杂质A;伏氧西汀杂质1
|
C17H20N2S |
284.4191 | |
|
Vortioxetine Impurity 8
|
2135576-73-5 |
沃替西汀杂质8
|
|
|||
|
Vortioxetine Impurity 14
|
1240670-85-2 |
VORTIOXETINE杂质T
|
VORTIOXETINE杂质T;沃替西汀杂质14;伏硫西汀杂质14;沃替西汀杂质S:1-[2-(2,4-二甲基苯基)磺酰苯基]-4-(2-哌嗪-1-苯基)哌嗪;沃替西汀杂质T;伏氧西汀杂质14
|
C28H34N4S |
458.66136 | |
|
Vortioxetine Impurity 5
|
1446750-99-7 |
沃替西汀杂质2
|
沃替西汀杂质R:1-(2-哌嗪-1-苯基)哌嗪;伏硫西汀杂质20;沃替西汀杂质20
|
C14H22N4 |
246.35128 |
药智官方微信
药智官方微博
